Cargando…
Discovery of Oligosaccharide Antigens for Semi‐Synthetic Glycoconjugate Vaccine Leads against Streptococcus suis Serotypes 2, 3, 9 and 14
Streptococcus suis bacteria are one of the most serious health problems for pigs and an emerging zoonotic agent in humans working in the swine industry. S. suis bacteria express capsular polysaccharides (CPS) a major bacterial virulence factor that define the serotypes. Oligosaccharides resembling t...
Autores principales: | Zhang, Shuo, Sella, Mauro, Sianturi, Julinton, Priegue, Patricia, Shen, Dacheng, Seeberger, Peter H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252040/ https://www.ncbi.nlm.nih.gov/pubmed/33852172 http://dx.doi.org/10.1002/anie.202103990 |
Ejemplares similares
-
Synthesis of Oligosaccharides Resembling the Streptococcus suis Serotype 18 Capsular Polysaccharide as
a Basis for Glycoconjugate Vaccine Development
por: Singh, Rajat Kumar, et al.
Publicado: (2022) -
Semi‐Synthetic Glycoconjugate Vaccine Lead Against Acinetobacter baumannii 17978
por: Sianturi, Julinton, et al.
Publicado: (2022) -
Synthesis of Streptococcus pneumoniae serotype 9V oligosaccharide antigens
por: Parameswarappa, Sharavathi G, et al.
Publicado: (2020) -
Development of an Efficacious, Semisynthetic Glycoconjugate
Vaccine Candidate against Streptococcus pneumoniae Serotype 1
por: Schumann, Benjamin, et al.
Publicado: (2018) -
Meningitis Caused by Streptococcus suis Serotype 14, North America
por: Haleis, Ahmed, et al.
Publicado: (2009)